Bogus voting:CEO seeks report over complaint against UDF

Agencies
April 30, 2019

Thiruvananthapuram, Apr 30: The controversy over bogus votes in the April 23 Lok Sabha polls continued in Kerala, with the Chief Electoral Officer Tuesday seeking an urgent report on complaints of fake votes allegedly by the opposition UDF workers in Kannur and Kasaragod constituencies.

CEO, Teeka Rama Meena said here that the report was sought from the District Collectors of Kannur and Kasaragod in view of the complaints of the ruling CPI(M)-headed LDF on the alleged bogus voting by the activists of Indian Union Muslim League (IUML), an ally of the Congress led UDF.

The Left Democratic Front (LDF) had released 'digital evidence' of the alleged bogus voting by two men, suspected to be IUML workers, in a polling booth in Kasaragod.

The CEO's move comes a day after he had confirmed that three women activists of the ruling CPI(M), including a serving panchayat member, cast bogus votes in Kasaragod.

"There will not be any compromise in the actions taken against bogus votes. We are seeing the issue with utmost seriousness. The complaints will be looked into once the reports come," Meena told reporters here.

IUML general secretary K P A Majeed said in Malappuram that the party would look into the allegations after getting a preliminary report from the local units in this regard.

Meanwhile, in an embarrassment to the state police force, local television channels Tuesday aired a purported voice message by some police personnel speaking about rigging in their postal votes.

The audio clip, reportedly circulated in a social media group of the police, could be heard asking postal votes for the police to be given in advance.

While Meena said the complaint on alleged malpractices in postal votes of police was yet to come to his notice, DGP Loknath Behera said "very serious action" would be taken against the guilty if the charges were proved to be correct.

Meanwhile, CPI(M) state secretary Kodiyeri Balakrishnan criticised the Chief Electoral Officer and alleged that Meena was acting in accordance with the UDF's ploy.

"On what basis has the CEO confirmed that the accused had cast bogus vote? The official has no power to ask an elected panchayat member (who faced allegation on the issue) to step down from her position," he told reporters in Kannur.

The CEO was not supposed to take decisions in accordance with the 'media trial' based on the visuals of the alleged bogus voting, he said, adding the CPI(M) was prepared to face any probe over the matter.

On Monday, the CPI(M) had rejected the bogus voting charge and justified the accused women, saying they were doing "open voting" and 'assisting' certain voters who were "unable" to exercise their franchise independently and had welcomed any probe into the charge.

Asked about the term "open voting" used by the Left to defend the presence of its party workers in the video, Meena had said he was hearing the term for the first time.

"As per our law, there is no open vote.

When I asked the Collector about this, he told me the term might have been used in colloquial parlance for assisted or companion vote.

Maybe there is a local reference like that.

Even companion vote, the voter must be present inside the booth.They could have brought the voter in wheel chair," Meena had told reporters yesterday.

Triggering widespread controversy, local television channels had aired the CCTV visuals, allegedly showing the three women voting more than twice at polling booth number 17 and 19 at AUP School Pilathara in Kannur district, which is part of Kasaragod constituency.

The video had also shown some local leaders inside the polling booth while the voting took place.

Kasaragod is considered the stronghold of CPI(M), which last tasted defeat here in 1984.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 10,2020

New Delhi, May 10: India's COVID-19 count crossed 60 thousand on Sunday, with Maharashtra being the worst-affected due to the infection so far, according to the Union Ministry of Health and Family Welfare.

The number of total confirmed cases in the country rose to 62,939, including 19,358 patients who have been cured and discharged or migrated, according to the Ministry.

The total number of active cases in the country, therefore, stands at 41,472.

The number of deaths in the country due to the infection reached 2,109 on Sunday.

While Maharashtra, with 20,228 cases is the worst-affected state, it is followed by Gujarat with 7,796 and the national capital, Delhi, with 6,542 cases. Tamil Nadu, is marginally behind Delhi with 6,535 cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 4,2020

New Delhi, Aug 4: Over 50 per cent of COVID-19 deaths in India have taken place among people aged 60 years and above and 37 per cent deaths have been reported among patients in the age group of 45 to 60 years, Health Ministry said on Tuesday.

Addressing a press conference, Rajesh Bhushan, Secretary, Health Ministry said that 11 per cent COVID-19 deaths took place in the age group of 26 to 44.

The 18 to 25 age group and those below 18 years reported one per cent deaths each.
"Currently, 5,86,298 active COVID-19 cases are in India and over 12 lakh people have recovered.

50 per cent deaths due to COVID19 have taken place among the age group of 60 years or above and 37 per cent deaths took place in the age group between 45 to 60 years," Bhushan said.

"A total of 11 per cent COVID-19 deaths took place in the age group of 26 to 44. Only 1 per cent in 18 to 25 age group and 1 per cent in below the age of 18 years," he added.

Bhushan said that 68 per cent of COVID-19 deaths have been reported among male patients and 32 per cent among female patients which is broadly in line with the global scenario.

The number of recovered COVID-19 patients in India is increasing daily and is now over double the number of active cases.

Bhushan said that the case fatality rate (CFR) is lowest since the first lockdown.

"More than 2 crore COVID-19 tests have been conducted, including more than 6.6 lakh tests in the last 24 hours. Recovered cases are now double of the active cases. 

The case fatality rate (CFR) is lowest since the first lockdown," he said
"This is the first time after the first lockdown that the fatality rate is at the lowest, at 2.10 per cent. The fatality rate has seen a progressive decline and it is continuing, which is a good sign," he added.

According to the World Health Organisation, CFR is a measure of the severity of a disease and is defined as the proportion of reported cases of a specified disease or condition which are fatal within a specified time.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.